相似文献
1
Pharmacological inhibition of bromodomain-containing proteins in inflammation.
Cold Spring Harb Perspect Biol. 2014 Jun 2;6(6):a018671. doi: 10.1101/cshperspect.a018671.
2
RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease.
Mol Pharmacol. 2017 Dec;92(6):694-706. doi: 10.1124/mol.117.110379. Epub 2017 Sep 29.
3
Discovery of Benzo[]indol-2(1)-ones and Pyrrolo[4,3,2-]quinolin-2(1)-ones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain with Potential High Efficiency against Acute Gouty Arthritis.
J Med Chem. 2019 Dec 26;62(24):11080-11107. doi: 10.1021/acs.jmedchem.9b01010. Epub 2019 Dec 13.
4
Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer.
Cancer Lett. 2017 May 28;394:76-87. doi: 10.1016/j.canlet.2017.02.021. Epub 2017 Feb 27.
5
BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation.
Front Immunol. 2019 Apr 9;10:678. doi: 10.3389/fimmu.2019.00678. eCollection 2019.
6
BET Bromodomain Inhibitors Suppress Inflammatory Activation of Gingival Fibroblasts and Epithelial Cells From Periodontitis Patients.
Front Immunol. 2019 Apr 30;10:933. doi: 10.3389/fimmu.2019.00933. eCollection 2019.
7
Suppression of inflammation by a synthetic histone mimic.
Nature. 2010 Dec 23;468(7327):1119-23. doi: 10.1038/nature09589. Epub 2010 Nov 10.
8
The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation.
Br J Pharmacol. 2017 Jan;174(1):101-115. doi: 10.1111/bph.13657. Epub 2016 Nov 18.
9
Domain-selective targeting of BET proteins in cancer and immunological diseases.
Curr Opin Chem Biol. 2020 Aug;57:184-193. doi: 10.1016/j.cbpa.2020.02.003. Epub 2020 Jul 30.
10
BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Oncotarget. 2016 Jul 12;7(28):43504-43517. doi: 10.18632/oncotarget.9762.
引用本文的文献
1
NLRP3-inflammasome Related Genes as Emerging Biomarkers and Therapeutic Targets in Psoriasis.
Inflammation. 2025 Mar 3. doi: 10.1007/s10753-025-02271-y.
2
Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections.
Proc Natl Acad Sci U S A. 2022 May 31;119(22):e2122506119. doi: 10.1073/pnas.2122506119. Epub 2022 May 27.
3
Case Report: 7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth.
Front Pharmacol. 2021 Apr 29;12:664176. doi: 10.3389/fphar.2021.664176. eCollection 2021.
4
Benefit of Apabetalone on Plasma Proteins in Renal Disease.
Kidney Int Rep. 2017 Dec 8;3(3):711-721. doi: 10.1016/j.ekir.2017.12.001. eCollection 2018 May.
5
Selective BET bromodomain inhibition as an antifungal therapeutic strategy.
Nat Commun. 2017 May 18;8:15482. doi: 10.1038/ncomms15482.
6
Epigenetic Determinants of Cancer.
Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a019505. doi: 10.1101/cshperspect.a019505.
7
BET Inhibition Attenuates Helicobacter pylori-Induced Inflammatory Response by Suppressing Inflammatory Gene Transcription and Enhancer Activation.
J Immunol. 2016 May 15;196(10):4132-42. doi: 10.4049/jimmunol.1502261. Epub 2016 Apr 15.
8
Histone Modifications and Cancer.
Cold Spring Harb Perspect Biol. 2016 Apr 1;8(4):a019521. doi: 10.1101/cshperspect.a019521.
9
A Structural Perspective on Readout of Epigenetic Histone and DNA Methylation Marks.
Cold Spring Harb Perspect Biol. 2016 Mar 1;8(3):a018754. doi: 10.1101/cshperspect.a018754.
10
Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells.
J Mol Cell Biol. 2016 Aug;8(4):349-62. doi: 10.1093/jmcb/mjv060. Epub 2015 Oct 12.
本文引用的文献
1
Bromodomain and extraterminal domain inhibitors (BETi) for cancer therapy: chemical modulation of chromatin structure.
Cold Spring Harb Perspect Biol. 2014 Dec 1;6(12):a018663. doi: 10.1101/cshperspect.a018663.
2
Epigenetic control of immunity.
Cold Spring Harb Perspect Biol. 2014 Jun 2;6(6):a019307. doi: 10.1101/cshperspect.a019307.
3
Suppression of inflammation by a synthetic histone mimic.
Nature. 2010 Dec 23;468(7327):1119-23. doi: 10.1038/nature09589. Epub 2010 Nov 10.
4
Selective inhibition of BET bromodomains.
Nature. 2010 Dec 23;468(7327):1067-73. doi: 10.1038/nature09504. Epub 2010 Sep 24.
5
Selective transcription in response to an inflammatory stimulus.
Cell. 2010 Mar 19;140(6):833-44. doi: 10.1016/j.cell.2010.01.037.
6
Transcriptional control of the inflammatory response.
Nat Rev Immunol. 2009 Oct;9(10):692-703. doi: 10.1038/nri2634.
7
Control of inducible gene expression by signal-dependent transcriptional elongation.
Cell. 2009 Jul 10;138(1):129-45. doi: 10.1016/j.cell.2009.05.047.
8
Points of control in inflammation.
Nature. 2002;420(6917):846-52. doi: 10.1038/nature01320.
Zotero 插件